Breast Cancer 1999
DOI: 10.1007/978-1-59259-456-6_23
|View full text |Cite
|
Sign up to set email alerts
|

Drug Resistance in Breast Cancer

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2008
2008
2016
2016

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 6 publications
(2 citation statements)
references
References 200 publications
0
2
0
Order By: Relevance
“…Increased drug efflux is a common mechanism of resistance in cancer cells, which is frequently seen following exposure of tumor cells to one of the "naturally occurring" anticancer drugs like doxorubicin, vincristine, etoposide, paclitaxel etc. (1). The increased drug efflux is mediated by membrane transporter proteins.…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…Increased drug efflux is a common mechanism of resistance in cancer cells, which is frequently seen following exposure of tumor cells to one of the "naturally occurring" anticancer drugs like doxorubicin, vincristine, etoposide, paclitaxel etc. (1). The increased drug efflux is mediated by membrane transporter proteins.…”
Section: Introductionmentioning
confidence: 99%
“…These membrane proteins are physiological pumps that remove unwanted chemicals. MDR1 is the most commonly used membrane pump that is involved in conferring resistance to cancer chemotherapy (1). A second family of such pumps has gained attention due to their ability to modulate drug resistance, the multidrug resistance-associated proteins (MRPs).…”
Section: Introductionmentioning
confidence: 99%